ID: ALA3235629

Max Phase: Preclinical

Molecular Formula: C33H32ClN5O2

Molecular Weight: 566.11

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1ccc(Oc2ccccc2N/C(=N/c2ccccc2)NCCCCNc2ccnc3cc(Cl)ccc23)cc1

Standard InChI:  InChI=1S/C33H32ClN5O2/c1-40-26-14-16-27(17-15-26)41-32-12-6-5-11-30(32)39-33(38-25-9-3-2-4-10-25)37-21-8-7-20-35-29-19-22-36-31-23-24(34)13-18-28(29)31/h2-6,9-19,22-23H,7-8,20-21H2,1H3,(H,35,36)(H2,37,38,39)

Standard InChI Key:  YDTRHFABVNPHPT-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 566.11

Molecular Weight (Monoisotopic): 565.2245

AlogP: 8.27

#Rotatable Bonds: 11

Polar Surface Area: 79.80

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: 2

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa:

CX Basic pKa: 8.00

CX LogP: 7.00

CX LogD: 6.18

Aromatic Rings: 5

Heavy Atoms: 41

QED Weighted: 0.08

Np Likeness Score: -1.12

References

1. Mishra A, Batchu H, Srivastava K, Singh P, Shukla PK, Batra S..  (2014)  Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.,  24  (7): [PMID:24630564] [10.1016/j.bmcl.2014.02.044]

Source

Source(1):

• Scientific Literature